Grace Therapeutics (GRCE) Selling, General & Administrative (2019 - 2026)
Grace Therapeutics' Selling, General & Administrative came in at $1.69 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 21.0% from $2.14 million a year earlier and down 34.9% from the prior quarter.
Grace Therapeutics (GRCE) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Grace Therapeutics reported Selling, General & Administrative of $8.23 million, up 16.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $8.67 million, up 21.0% from FY2025.
- Selling, General & Administrative carries a five-year compound annual growth rate of 9.5% (FY2021 to FY2026).
- Going back by fiscal year, Selling, General & Administrative was $7.17 million in FY2025 (+7.2%), $6.68 million in FY2024 (-12.2%), $7.61 million in FY2023 (-17.8%) and $9.26 million in FY2022 (+67.8%).
- The fiscal Q1 2027 figure represents the lowest quarterly Selling, General & Administrative since fiscal Q4 2025.
- Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 10.6%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in fiscal Q2 2022 (growth of 123.3%), and the weakest in fiscal Q2 2023 (a decline of 43.2%).
- Business Quant data shows GRCE's Selling, General & Administrative at $2.59 million (Q4 2026), $1.99 million (Q3 2026) and $1.96 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Grace Therapeutics | 34.99 Mn | 34.99 Mn | - | 1.69 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 1.82 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 2.96 Mn |
Grace Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();